000			01593 a2200493 4500
005			20250511164108.0
264		0	_c19760706
008			197607s 0 0 eng d
022			_a0007-1048
024	7		_a10.1111/j.1365-2141.1976.tb01872.x _2doi
040			_aNLM _beng _cNLM
100	1		_aLampkin, B C
245	0	0	_aManipulation of the mitotic cycle in the treatment of acute myelogenous leukaemia. _h[electronic resource]
260			_bBritish journal of haematology _cJan 1976
300			_a29-40 p. _bdigital
500			_aPublication Type: Journal Article; Research Support, U.S. Gov't, P.H.S.
650	0	4	_aAdolescent
650	0	4	_aAdult
650	0	4	_aBone Marrow Examination
650	0	4	_aChild
650	0	4	_aChild, Preschool
650	0	4	_aCytarabine _xadministration & dosage
650	0	4	_aDNA _xbiosynthesis
650	0	4	_aDaunorubicin _xtherapeutic use
650	0	4	_aDoxorubicin _xtherapeutic use
650	0	4	_aFemale
650	0	4	_aHumans
650	0	4	_aInfant
650	0	4	_aInfant, Newborn
650	0	4	_aInfusions, Parenteral
650	0	4	_aLeukemia, Myeloid, Acute _xdrug therapy
650	0	4	_aMale
650	0	4	_aMiddle Aged
650	0	4	_aMitosis _xdrug effects
650	0	4	_aRemission, Spontaneous
650	0	4	_aTime Factors
700	1		_aMcWilliams, N B
700	1		_aMauer, A M
700	1		_aFlessa, H C
700	1		_aHake, D A
700	1		_aFisher, V
773	0		_tBritish journal of haematology _gvol. 32 _gno. 1 _gp. 29-40
856	4	0	_uhttps://doi.org/10.1111/j.1365-2141.1976.tb01872.x _zAvailable from publisher's website
999			_c1070327 _d1070327